Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.990
-0.140 (-4.47%)
At close: Aug 28, 2026, 4:00 PM EDT
2.989
-0.001 (-0.03%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$383,000
Market Cap
277.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 34 | -8 | -19.05% |
| Sep 30, 2024 | 42 | 2 | 5.00% |
| Sep 30, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2022 | 38 | 13 | 52.00% |
| Sep 30, 2021 | 25 | 5 | 25.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Fate Therapeutics | 161 |
| Lineage Cell Therapeutics | 77 |
| Cartesian Therapeutics | 75 |
| Neumora Therapeutics | 63 |
| Pyxis Oncology | 56 |
| ALX Oncology Holdings | 48 |
| Surrozen | 44 |
AVXL News
- Just now - Anavex Life Sciences Quarterly report: Q2 2026 - Filings
- 3 days ago - Anavex Life Sciences Proxy statement: Proxy filing - Filings
- 5 days ago - Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 5 days ago - Anavex Life Sciences Earnings release: Q3 2026 - Filings
- 5 days ago - Anavex Life Sciences Quarterly report: Q3 2026 - Filings
- 6 days ago - Anavex Life Sciences Proxy statement: Proxy filing - Filings
- 13 days ago - Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - GlobeNewsWire
- 13 days ago - Anavex Life Sciences Proxy statement: Proxy filing - Filings